SAINT LAURENT, Quebec, and NEW YORK, March 15, 2021 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQB:IGXT) (the “Corporation”) today announced that its wholly owned subsidiary, IntelGenx Corp. (“IntelGenx”), a leader in pharmaceutical films, has agreed to the terms of a strategic partnership with atai Life Sciences (“atai”), a clinical-stage biopharmaceutical company aiming to…


Previous articleNuminus Wellness Inc. Announces $30 Million Bought Deal Public Offering
Next articleDC’s Initiative 81 Becomes Law: Effectively Decriminalizes Entheogenic Plants and Fungi